The University of Southampton in the UK released news on the 6th that a tetanus-diphtheria vaccine that does not require refrigeration has achieved positive results in clinical trials. Once this vaccine is developed and mature and put into use, it is expected to improve vaccine supply in remote areas and reduce carbon emissions from cold chain storage and transportation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.